Protalix BioTherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2014 | 82.1% | -810.6% | -849.9% |
| FY2015 | 83.3% | -542.4% | 1,329.9% |
| FY2016 | 8.7% | -360.5% | -319.2% |
| FY2017 | 19.0% | -163.8% | -395.9% |
| FY2018 | 72.8% | -56.4% | -77.3% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2014 | 82.1% | -810.6% | -849.9% |
| FY2015 | 83.3% | -542.4% | 1,329.9% |
| FY2016 | 8.7% | -360.5% | -319.2% |
| FY2017 | 19.0% | -163.8% | -395.9% |
| FY2018 | 72.8% | -56.4% | -77.3% |